Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY

Characterization of drug-neutralizing antibodies in patients with Fabry disease during infusion

(2018) Malte Lenders et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease

(2017) M. Lenders et al.   JOURNAL OF INTERNAL MEDICINE

Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes

(2017) Albina Nowak et al.   MOLECULAR GENETICS AND METABOLISM

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

(2016) Maarten Arends et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction

(2016) Priya S. Kishnani et al.   MOLECULAR GENETICS AND METABOLISM

Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease

(2016) Xiaoxia Pan et al.   PLoS One

X-chromosome inactivation in female patients with Fabry disease

(2015) L. Echevarria et al.   CLINICAL GENETICS

Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease

(2015) M. Lenders et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

(2013) F. Weidemann et al.   JOURNAL OF INTERNAL MEDICINE

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Globotriaosylsphingosine Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease

(2012) Mehdi Namdar et al.   PLoS One

Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome

(2012) Saskia M. Rombach et al.   PLoS One

Anti-α-galactosidase A antibody response to agalsidase beta treatment: Data from the Fabry Registry

(2011) William R. Wilcox et al.   MOLECULAR GENETICS AND METABOLISM

Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy

(2010) M. D. Sanchez-Nino et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

(2009) R. Schiffmann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION